Volitionrx (VNRX) Free Cash Flow (2011 - 2025)
Volitionrx (VNRX) posted Free Cash Flow of -$5.5 million for Q4 2025, down 51.56% on a QoQ basis from -$3.6 million in Q3 2025, and little changed year-over-year from -$5.5 million in Q4 2024.
Volitionrx (VNRX) Free Cash Flow (2011 - 2025) Analysis & Trends
Volitionrx's Free Cash Flow history runs 15 years deep, the most recent figure standing at -$5.5 million for Q4 2025.
- Quarterly Free Cash Flow changed 0.03% year-over-year to -$5.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$19.8 million (up 24.45% YoY) and the FY2025 annual result came in at -$19.8 million, up 24.45% from the prior year.
- Free Cash Flow was -$5.5 million for Q4 2025 at Volitionrx, down from -$3.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $6.4 million in Q4 2023 and bottomed at -$8.7 million in Q1 2023.
- A 5-year average of -$5.1 million and a median of -$6.0 million in 2021 frame the typical range for Free Cash Flow.
- Peak annual rise in Free Cash Flow reached 201.02% in 2023, while the deepest fall reached 350.87% in 2023.
- Volitionrx's Free Cash Flow stood at -$4.5 million in 2021, then slumped by 40.65% to -$6.4 million in 2022, then soared by 201.02% to $6.4 million in 2023, then plunged by 185.37% to -$5.5 million in 2024, then grew by 0.03% to -$5.5 million in 2025.
- Business Quant data shows VNRX's Free Cash Flow at -$5.5 million in Q4 2025, -$3.6 million in Q3 2025, and -$6.3 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.09 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 449.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 305.56 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 112.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Volitionrx | 109,643.10 | -2.35 Mn | - | -5.50 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -5.50 Mn |
| Dec 31, 2025 | -5.50 Mn |
| Sep 30, 2025 | -3.63 Mn |
| Sep 30, 2025 | -3.63 Mn |
| Jun 30, 2025 | -6.34 Mn |
| Jun 30, 2025 | -6.34 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Mar 31, 2025 | -4.30 Mn |
| Dec 31, 2024 | -5.50 Mn |
| Dec 31, 2024 | -5.50 Mn |
| Sep 30, 2024 | -5.52 Mn |
| Sep 30, 2024 | -5.52 Mn |
| Jun 30, 2024 | -6.75 Mn |
| Jun 30, 2024 | -6.75 Mn |
| Mar 31, 2024 | -8.39 Mn |
| Mar 31, 2024 | -8.39 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Dec 31, 2023 | 6.45 Mn |
| Sep 30, 2023 | -7.92 Mn |
| Sep 30, 2023 | -7.92 Mn |